These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 29750335)
1. Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome. Adar T; Rodgers LH; Shannon KM; Yoshida M; Ma T; Mattia A; Lauwers GY; Iafrate AJ; Hartford NM; Oliva E; Chung DC Cancer; 2018 Aug; 124(15):3145-3153. PubMed ID: 29750335 [TBL] [Abstract][Full Text] [Related]
2. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668 [TBL] [Abstract][Full Text] [Related]
3. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579 [TBL] [Abstract][Full Text] [Related]
4. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China. Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542 [TBL] [Abstract][Full Text] [Related]
5. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419 [TBL] [Abstract][Full Text] [Related]
6. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759 [TBL] [Abstract][Full Text] [Related]
7. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer. Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC; JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542 [TBL] [Abstract][Full Text] [Related]
8. Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients. Kato A; Sato N; Sugawara T; Takahashi K; Kito M; Makino K; Sato T; Shimizu D; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Kumagai J; Terada Y Am J Surg Pathol; 2016 Jun; 40(6):770-6. PubMed ID: 26848797 [TBL] [Abstract][Full Text] [Related]
9. Lynch Syndrome in Thai Endometrial Cancer Patients. Manchana T; Ariyasriwatana C; Triratanachat S; Phowthongkum P Asian Pac J Cancer Prev; 2021 May; 22(5):1477-1483. PubMed ID: 34048176 [TBL] [Abstract][Full Text] [Related]
10. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Mills AM; Liou S; Ford JM; Berek JS; Pai RK; Longacre TA Am J Surg Pathol; 2014 Nov; 38(11):1501-9. PubMed ID: 25229768 [TBL] [Abstract][Full Text] [Related]
11. Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers. Evans DG; Lalloo F; Ryan NA; Bowers N; Green K; Woodward ER; Clancy T; Bolton J; McVey RJ; Wallace AJ; Newton K; Hill J; McMahon R; Crosbie EJ J Med Genet; 2022 Apr; 59(4):328-334. PubMed ID: 33452216 [TBL] [Abstract][Full Text] [Related]
12. Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer. Kim SR; Tone A; Kim RH; Cesari M; Clarke BA; Eiriksson L; Hart TL; Aronson M; Holter S; Lytwyn A; Maganti M; Oldfield L; Gallinger S; Bernardini MQ; Oza AM; Djordjevic B; Lerner-Ellis J; Van de Laar E; Vicus D; Pugh TJ; Pollett A; Ferguson SE Cancer; 2021 Sep; 127(17):3082-3091. PubMed ID: 33983630 [TBL] [Abstract][Full Text] [Related]
13. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas. Ju JY; Mills AM; Mahadevan MS; Fan J; Culp SH; Thomas MH; Cathro HP Am J Surg Pathol; 2018 Nov; 42(11):1549-1555. PubMed ID: 30148743 [TBL] [Abstract][Full Text] [Related]
14. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409 [TBL] [Abstract][Full Text] [Related]
15. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center. Moline J; Mahdi H; Yang B; Biscotti C; Roma AA; Heald B; Rose PG; Michener C; Eng C Gynecol Oncol; 2013 Jul; 130(1):121-6. PubMed ID: 23612316 [TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer]. Jin W; Wang LQ; Liu Y; Liu AJ Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020 [No Abstract] [Full Text] [Related]
17. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening. Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703 [TBL] [Abstract][Full Text] [Related]
18. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report. Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350 [TBL] [Abstract][Full Text] [Related]
19. Testing strategies to reduce morbidity and mortality from Lynch syndrome. Keränen A; Ghazi S; Carlson J; Papadogiannakis N; Lagerstedt-Robinson K; Lindblom A Scand J Gastroenterol; 2018 Dec; 53(12):1535-1540. PubMed ID: 30572730 [TBL] [Abstract][Full Text] [Related]
20. Initial screening by immunohistochemistry is effective in universal screening for Lynch syndrome in endometrial cancer patients: a prospective observational study. Tsuruta T; Todo Y; Yamada R; Kuwahara K; Kurosu H; Minowa K; Minoura Y; Minobe S; Suzuki H; Kato H Jpn J Clin Oncol; 2022 Jul; 52(7):752-758. PubMed ID: 35438162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]